|
Alumnus/na of the Year Awards |
|
| 2009: |
Greg A. Gerhardt ('79) |
| 2008: |
Lanny (’62, ’64) & Beth (Fisher) (’63) Morley |
|
2007: |
Randa Rawlins ('79) |
|
2006: |
|
|
2005: |
Eugene Croarkin Sr. ('49, '52) |
|
2004: |
Dwain Horn ('50) |
|
2003: |
Calvin Roebuck ('57) |
|
2002: |
Linda Miller ('70) |
|
2001: |
Dean Rosebery ('41) & Amy (Ayres) ('43) Rosebery |
|
2000: |
Carole Kennedy ('72) |
|
1999: |
Chuck Foudree ('66) |
|
1998: |
Bud Hunter ('50) |
|
1997: |
Joseph Hasenstab ('60) |
|
1996: |
Steve Gaw ('78) & Fannie (Bowdish) Gaw ('84) |
|
1995: |
James C.C. Chen ('86) |
|
1994: |
Ruth Warner Towne ('39) |
|
1993: |
Frederick "Fritz" Lauer ('50) |
|
1992: |
Ray Bentele ('60) & Mary (Cox) Bentele ('60) |
|
1991: |
Larry Moore ('67) |
As
one of the nation’s foremost researchers on Parkinson’s disease, Dr. Greg
A.
Gerhardt attributes much of his success to his educational experience at
Truman.Gerhardt received his bachelor of science
in chemistry magna cum laude
from Truman State University (then Northeast Missouri State University) in 1979.
He received additional training in chemistry and neuroscience at the University
of Kansas where he earned his Ph.D. with honors in 1983, and he received
training as a postdoctoral fellow from 1983-1985 in pharmacology and psychiatry
at the University of Colorado Health Sciences Center in Denver. He remained at
the University of Colorado from 1985-1999 where he rose through the ranks to
professor (with tenure) of psychiatry, pharmacology and The Neuroscience
Training Program.
He is currently RCTF professor with tenure, Departments of Anatomy & Neurobiology, Neurology, Psychiatry and Electrical Engineering at the University of Kentucky. Since 1999, he has served as director of the Morris K. Udall Parkinson’s Disease Research Center of Excellence at the University of Kentucky Chandler Medical Center, Lexington, Ky., one of 15 NIH funded Centers for the development of new treatments for Parkinson’s disease. He is also the director of the Center for Microelectrode Technology.
His research focuses on Parkinson’s disease and the repair of
damaged dopamine neurons in the basal ganglia of the brain using growth factors
such as GDNF. His laboratory also develops microelectrode technologies to
directly measure neuronal cell firing and neurotransmission in the living brain,
and technologies to repair the brain through brain machine interfaces.
Since 1999, Gerhardt has been
editor-in-chief (Americas and Australia) for the
Through his
estate, Gerhardt has committed $1 million to create the Greg A. and Paulette C.
Danielle-Gerhardt Endowed Professorship at Truman to commemorate his late wife,
Paulette. “I have allegiance to several universities, and we felt compassion to
support them all, but Truman is the school where we felt we could make the most
impact,” says Gerhardt.
The Greg A. and Paulette C. Danielle-Gerhardt
Endowed Professorship will support a professor in chemistry or biology with a
preference given to those teaching or researching neuroscience.